StockData
Progyny, Inc. logo

Progyny, Inc. (PGNY) stock

PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/304% above fair value
$36.71−0.44 (-1.18%)

Close on Nov 17, 2026Market cap $2.82BP/E 39.9Yield –

Progyny operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Progyny's operating income for the twelve months ending Jun 30, 2026 was $112.13M, up 46.1% year over year. For fiscal 2025 it was $85.28M, up 26.4% from the year before. The highest annual figure on record is $85.28M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$85.28M+26.4%
FY2024Dec 31, 2024$67.46M+8.5%
FY2023Dec 31, 2023$62.18M+166.4%
FY2022Dec 31, 2022$23.34M-27.8%
FY2021Dec 31, 2021$32.34M+287.4%
FY2020Dec 31, 2020$8.35M-13.7%
FY2019Dec 31, 2019$9.68M–
FY2018Dec 31, 2018-$3.45M–
FY2017Dec 31, 2017-$11.01M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$40.00M+64.2%
Q1 FY2026Mar 31, 2026$35.38M+46.4%
Q4 FY2025Dec 31, 2025$15.22M-3.6%
Q3 FY2025Sep 30, 2025$21.53M+72.8%
Q2 FY2025Jun 30, 2025$24.36M+17.7%
Q1 FY2025Mar 31, 2025$24.17M+30.5%
Q4 FY2024Dec 31, 2024$15.79M+14.4%
Q3 FY2024Sep 30, 2024$12.46M-31.5%
Q2 FY2024Jun 30, 2024$20.69M+36.2%
Q1 FY2024Mar 31, 2024$18.52M+23.4%
Q4 FY2023Dec 31, 2023$13.80M+317.4%
Q3 FY2023Sep 30, 2023$18.19M+61.6%
Q2 FY2023Jun 30, 2023$15.18M+71.8%
Q1 FY2023Mar 31, 2023$15.01M–
Q4 FY2022Dec 31, 2022$3.31M–
Q3 FY2022Sep 30, 2022$11.26M+24.2%
Q2 FY2022Jun 30, 2022$8.84M-24.2%
Q1 FY2022Mar 31, 2022-$58.00K-100.5%
Q4 FY2021Dec 31, 2021-$188.00K-116.2%
Q3 FY2021Sep 30, 2021$9.07M+87.8%
Q2 FY2021Jun 30, 2021$11.66M–
Q1 FY2021Mar 31, 2021$11.81M+244.1%
Q4 FY2020Dec 31, 2020$1.16M+1.5%
Q3 FY2020Sep 30, 2020$4.83M+57.3%
Q2 FY2020Jun 30, 2020-$1.07M-145.5%
Q1 FY2020Mar 31, 2020$3.43M+10.3%
Q4 FY2019Dec 31, 2019$1.14M–
Q3 FY2019Sep 30, 2019$3.07M–
Q2 FY2019Jun 30, 2019$2.35M–
Q1 FY2019Mar 31, 2019$3.11M–
Q4 FY2018Dec 31, 2018-$703.00K–
Q3 FY2018Sep 30, 2018-$587.00K–
Q2 FY2018Jun 30, 2018-$317.00K–
Q1 FY2018Mar 31, 2018-$1.85M–

More Progyny figures

See a number that looks wrong?